Gynecological tumors, summit in Palermo: comparison on new diagnostic and therapeutic strategy
Focus on the integration of minimally invasive surgical approaches in the treatment of gynecological neoplasms and the growing role played by the methods of identifying the sentinel lymph node.
Ovarian carcinoma is among the first 5 causes of cancer death in women under the age of 50; The mortality rate in 2014 reached an average of 6.4 deaths per 100 thousand women. It is estimated that 1 in 74 women develop it in life. Over 5 thousand diagnoses in 2014; More than 5.700 expected for 2030.
The cherry tumor of the uterus, despite the spread of the Pap-Test, is the third malignant tumor of the reproductive system, with 1.580 new cases per year and two deaths per 100 thousand women.
Palermo, 1 December 2016 – Locally advanced tumors still represent the most important slice of gynecological neoplasms today. A timely diagnosis is still the main weapon to defeat these diseases. An important conference organized by Arnas Civico by Cristina Benfratelli and University of Palermo with the support of Aogoi, Association of Ostetrics and Italian Hospitali Associations Segi, Italian Society of Gynecological Endoscopy; Sigo, Italian society of gynecology and obstetrics; Agui, Association of Italian University Gynecologists.
“The meeting, a real refresher course, aims to provide participants with the tools to diagnose, study and treat women with locally advanced ovarian and cervical tumors,” says Vito Chiantera, UOC Director of Oncological Gynecology Arnas Civic Di Cristina Benfratelli and coordinator of the meeting. “Ovarian and cervical carcinoma, almost always presenting themselves in advanced form, forces the specialist to acquire a wealth of knowledge that goes far beyond classical gynecology, actually embracing radiotherapy and chemotherapy, abdominal and urological surgical techniques. This represents the true challenge of integrated treatments and diagnostic and surgical procedures. Ovarian carcinoma is among the first 5 causes of death from cancer among women under the age of 50 and the mortality rate has reached an average of 6.4 deaths per 100 thousand women.
It is estimated that in the course of life 1 out of 74 women develop and the over 5 thousand diagnoses of 2014 will calculate more than 5.700 in 2030. The cherry tumor of the uterus, despite the spread of the Pap-Test, is the third malignant tumor of the reproductive system, with 1.580 new cases per year and two deaths per 100 thousand women “, he adds.
The best Italian experts will treat the state of the art of modern cancer gynecology and the innovations that overlook the international scene. “The program organized for extremely practical -cut educational modules and live surgery will allow you to acquire the skills necessary to face these tumors – explains Chiantera. In particular, two aspects will be discussed: the progressive integration of tiny surgical approaches in the treatment of gynecological neoplasms and the growing role played by the methods of identifying the sentinel lymph node that are currently being studied to be used in international reference centers in gynecological neoplasms locally advanced.”
Already used in the case of breast and melanoma cancer, the technique of identifying sentinel lymph nodes, the first to be involved in the lymphatic system starting from the tumor headquarters, is in fact also applicable today in the Pelvic district. “It is possible to use this diagnostic method which, in case of negativity, excludes the need to remove all the lymph nodes, allowing less invasive interventions, with great advantage for the woman”, concludes Chiantera.
The congress in the Sicilian capital was designed by the newly formed unit of oncological gynecology, inaugurated in May, but with a high -complex surgical interventions with women with women with gynecological tumors. “Oncological gynecology completes the assistance offer of the ‘Maurizio Ascoli’ oncological Center of Cristina Benfratelli’s Civic Arnas, ensuring an response of excellence to the need for care of patients with reproductive system tumors thanks to a virtuous collaboration between universities and Regional Health Service which, in times of spending review, inaugurates a new and more efficient resource management methods “, underlines Giovanni Migliore, general manager Arnas Civico by Cristina Benfratelli.